Work

Identification and targeting of M-phase progression downstream of HER2 in trastuzumab-sensitive and -resistant breast cancer cell lines.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.612

Authors: E. Aubrey Thompson, Brian M. Necela, Jennifer M. Carr, Jennifer M. Kachergus, Daniel Serie, Krishna R. Kalari, Yan W. Asmann, Edith A. Perez

Institutions: Mayo Clinic in Florida, Mayo Clinic

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907524885

Cites:

Cited by:

Related to: 10